Active exploits, nation-state campaigns, fresh arrests, and critical CVEs — this week's cybersecurity recap has it all.
Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results